Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:B6E
Stock Latest News
Company Announcements
Sobi Adjusts Share Capital to Support Employee Incentive Programme
1d ago
Premium
Ratings
Sobi: Advancing Pacritinib Pipeline Supports Asymmetric Upside With Buy Rating and Maintained SEK575 Target
21d ago
Premium
Company Announcements
Sobi Completes Class C Share Issue to Fund Employee Incentive Programme
1M ago
Premium
Ratings
Aspaveli’s Enhanced Kidney Data Supports Global Growth; Analyst Reiterates Buy Rating and Maintains $575 Price Target
1M ago
Premium
Ratings
Buy Rating Reiterated on Sobi as Diversified Pipeline and Lacutamab Partnership Support Upside; 12‑Month SEK575 Price Target Unchanged
2M ago
Premium
Company Announcements
Sobi partners with Innate Pharma in $580m lacutamab deal to expand rare cancer portfolio
2M ago
Premium
Ratings
Sobi Reaffirmed at Buy as Analyst Trims Target to SEK560 Amid Long-Term Competitive Pressures
2M ago
Premium
Ratings
Mitchell Kapoor Reiterates Buy on Swedish Orphan Biovitrum, Maintains SEK575 12-Month Price Target Amid Solid Late-Stage Pipeline and CEO Transition
2M ago
Premium
Company Announcements
Sobi CEO Guido Oelkers to Step Down in Early 2027
2M ago
Premium
The Fly
Swedish Orphan Biovitrum price target raised to SEK 515 at Deutsche Bank
2M ago
Premium
The Fly
Swedish Orphan Biovitrum price target raised to SEK 575 at Berenberg
3M ago
Premium
The Fly
Biovitrum price target raised to SEK 575 from SEK 550 at H.C. Wainwright
3M ago
Premium
The Fly
Swedish Orphan Biovitrum downgraded to Hold from Buy at DNB Carnegie
3M ago
Premium
Company Announcements
Sobi lifts 2026 outlook as Q2 revenue surges and gout pipeline advances
3M ago
Premium
Company Announcements
Sobi Moves to Repurchase Class C Shares to Support Employee Incentive Programme
3M ago
Premium
Pre-Earnings
Is 0MTD a Buy, Before Earnings?
3M ago
Premium
The Fly
Swedish Orphan price target raised to SEK 530 from SEK 470 at Barclays
3M ago
Premium
The Fly
Swedish Orphan Biovitrum downgraded to Hold from Buy at Pareto
3M ago
Premium
Ratings
Buy Rating Reiterated on Sobi as NASP Delay Seen as Timing Issue; SEK 550 Price Target Maintained
3M ago
Premium
Company Announcements
Sobi hit with FDA manufacturing setback on NASP gout therapy, but efficacy concerns ruled out
3M ago
Premium
Ratings
Sobi Earns Reiterated Buy as Tryngolza Data Strengthen Growth Outlook; SEK550 Price Target Maintained
4M ago
Premium
Company Announcements
Sobi’s Tryngolza cuts pancreatitis risk 85% in severe hypertriglyceridemia trial analysis
4M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
